Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TYVASO vs UBLITUXIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TYVASO vs UBLITUXIMAB: Safety Overview

Metric TYVASO UBLITUXIMAB
Total FAERS Reports 524 1,582
Deaths Reported 148 27
Death Rate 28.2% 1.7%
Hospitalizations 286 213
Average Patient Age 62.2 yrs 49.7 yrs
% Female Patients N/A 73.4%
Manufacturer N/A TG Therapeutics, Inc.
Route N/A INTRAVENOUS